Dihexa – 10MG per vial

Clinical Test Expectation – Dihexa – Human Subjects : Used for treatment of brain and spinal cord damage caused by trauma. Stroke recovery. Improved cognitive function.Helps in the treatment of Alzheimer’s. Helps in the treatment of Parkinson’s. Improves short and long term memory. Helps manage depression. Enhances creative thinking. Improves brain focus
Strength – 10MG per vial

Introduction
Dihexa is a peptide that enhances the growth and development of neurons and synapses in the brain. Specifically, Dihexa has been shown to bind to and activate hepatocyte growth factor (HGF) receptors, which are found in high concentrations in the brain. Dihexa, also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amideor PNB-0408, is a relatively new drug for the treatment of Alzheimer’s disease (AD) and cognitive impairment. Unlike other drugs for AD, this potent nootropic does not only impede the progression of the disease but it actually repairs the damage in the synapse (junction) between neurons. Because of its regenerative properties, most medical professionals prescribe Dihexa for the treatment of a wide array of medical conditions that affect cognitive function.

The therapeutic value of Dihexa, lies in its capacity to encourage the formation of new functional synaptic connections among existing neurons, encourage the replacement of damaged and lost neurons from available neural stem cell populations, and facilitate cerebral blood flow and neuroprotection. Such treatment outcomes would benefit patients afflicted with AD and possibly those suffering from other neurodegenerative diseases.

Dosing Details – Please visit this link for Dosing instructions : https://researchpeptides.co.za/dosage-instructions/